Skystar Bio-Pharma (SKBI) Gains Exclusive Rights to Sell and Market Aquaculture Vaccine Through 2024; Gets Grade I from Chinese Ministry of Agriculture
Tweet Send to a Friend
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) today announced that it has gained exclusive rights to sell and market its aquaculture vaccine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
